Post-Merger Data Confidence: Unlocking the Full Value of Acquired ELNs

Preserve Access, Integrity, and Usability of Scientific Data Post-M&A

Effective data management is essential in the competitive landscape of pharmaceutical and biotech mergers and acquisitions (M&A). Data assets, especially those stored in Electronic Lab Notebooks (ELNs), are critical to ensuring continuity, compliance, and value realization. SciY offers an advanced ELN archiving and migration solution that ensures long-term accessibility and compliance, helping organizations protect their data assets and maximize post-merger value.

Download the Brochure

Input value is invalid.
Please enter your first name
Please enter your last name
Please enter your e-mail address
Please enter your Company/Institution

 

Privacy Settings

To learn on my personal data, please read Bruker´s Privacy Notice and  Terms of Use.

I agree to share my contact details with Bruker Corporation and its affiliates for the purpose of fulfilling my request.